surgery
endoscopic thoracic sympathectomy
- Regions
- hand, face and scalp, underarm
- Severity fit
- HDSS 4
- Type
- surgical procedure
Treatment · surgery
Endoscopic thoracic sympathectomy (ETS) is a surgical procedure that cuts or clamps the sympathetic nerve chain in the upper thorax to reduce sweating, primarily in the palms and face. It is highly effective for severe excessive hand sweating but carries the risk of compensatory sweating — increased sweating elsewhere on the body that can be permanent. Modern practice reserves ETS for severe disease that has failed all less-invasive options.
surgery
Sympathetic nerves originating in the upper thoracic spinal cord drive eccrine sweat glands in the upper body. ETS interrupts (by cutting, clamping, or cauterizing) the sympathetic chain at specific thoracic levels (typically T2-T4 for hand and face and scalp disease) to abolish sympathetic input to those regions.
Ecrina presents ETS as informational context, not as a treatment to seek. Modern practice has narrowed the indication: less invasive treatments (Botox, iontophoresis, pills that reduce sweating) have improved enough that ETS is reserved for severe excessive hand sweating (HDSS 4) that has not responded to less invasive options, with explicit informed consent about compensatory sweating risk. ETS for isolated underarm disease is rarely recommended given the availability of miraDry, Brella, Botox, and skin treatments.
Compensatory sweating, defined as increased sweating in regions not targeted by surgery (trunk, lower back, thighs), affects a meaningful proportion of ETS patients and can be permanent. The risk varies by surgical level, technique, and individual patient. For some patients, compensatory sweating is worse than the original problem. This risk is the central consideration in the modern indication for ETS.
Hand sweating typically resolves immediately after ETS, within hours of the procedure. The hands become dry, often unusually dry compared with baseline. Patient satisfaction with hand drying is high in the immediate post-operative period but is moderated over time by compensatory sweating in other regions.
Face and scalp sympathetic innervation is at higher thoracic levels (T2 in particular) and surgery for face and scalp disease can produce additional risks including Horner's syndrome (drooping eyelid, constricted pupil, decreased facial sweating on one side). Many surgeons decline to operate at T2 for face and scalp disease alone because of this risk; treatment alternatives are often preferred.
Discussion of ETS is reasonable when: (1) HDSS 4 hand (and sometimes face and scalp) disease, (2) demonstrated failure of or intolerance to antiperspirants applied to the skin, iontophoresis, Botox, and pills that reduce sweating, (3) patient understands the compensatory-sweating risk and accepts it as a tradeoff, (4) consultation with an experienced thoracic surgeon with excessive sweating-specific experience. ETS is irreversible; clamping techniques offer some reversibility but the practical reversibility window is limited.
Numbers and approved uses on this page link back to their sources governed in anna-pipeline. Each entry below is a packet bound to this treatment.
topical antiperspirant
prescription skin treatment that reduces sweating
prescription skin treatment that reduces sweating
device-based
pill that reduces sweating
pill that reduces sweating
Botox
energy-based procedure
energy-based procedure
surgery
·Related references
Conditions this treats
Outcome measures